| Net Cash Provided by (Used in) Operating Activities |
$191,093,000 |
USD |
53% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$108,867,000 |
USD |
-73% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
84,687,951 |
shares |
52% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$82,226,000 |
USD |
-5071% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$152,474,000 |
USD |
49% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$45,535,000 |
USD |
232% |
Q1 2025 |
Q1 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$899,000 |
USD |
-22% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$2,144,301,000 |
USD |
52% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
$1,235,000 |
USD |
3532% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$50,716,000 |
USD |
220% |
Q1 2024 |
Q1 2024 |